Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) 은(는) 상장 기업입니다 금융 섹터의 Shell Companies 산업에서 운영. 본사 소재지는 Fort Lauderdale, FL, 미국. 현재 CEO는 Roger Bendelac.
DMAA 을(를) 보유 IPO 날짜 2025-01-27, 2 명의 정규직 직원, 에 상장 NASDAQ Global Select, 시가총액 $353.27M.
Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
